Benjamin Bourgeois

1.8k total citations
15 papers, 252 citations indexed

About

Benjamin Bourgeois is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Benjamin Bourgeois has authored 15 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Oncology. Recurrent topics in Benjamin Bourgeois's work include FOXO transcription factor regulation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Benjamin Bourgeois is often cited by papers focused on FOXO transcription factor regulation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Benjamin Bourgeois collaborates with scholars based in Austria, Netherlands and Germany. Benjamin Bourgeois's co-authors include Tobias Madl, Peter Macheroux, Karl Gruber, Harald Sourij, Klaus Zangger, Emil Spreitzer, Marko Poglitsch, Florian Posch, Gerald Hackl and Wolf‐Dieter Lienhart and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin Bourgeois

15 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Bourgeois Austria	8	143	47	46	32	28	15	252
Toru Yanagimoto Japan	9	234 1.6×	34 0.7×	72 1.6×	36 1.1×	32 1.1×	12	408
Harini Srinivasan United States	8	155 1.1×	38 0.8×	34 0.7×	30 0.9×	24 0.9×	14	270
Franz-Xaver Beck Germany	9	125 0.9×	56 1.2×	28 0.6×	19 0.6×	20 0.7×	11	321
Zydrune Polianskyte-Prause Finland	8	202 1.4×	40 0.9×	34 0.7×	40 1.3×	40 1.4×	9	311
Guorui Zhang China	10	104 0.7×	33 0.7×	16 0.3×	43 1.3×	47 1.7×	27	281
Raffaele Raucci Italy	12	144 1.0×	48 1.0×	75 1.6×	77 2.4×	17 0.6×	17	352
Chen Qu China	8	179 1.3×	40 0.9×	40 0.9×	30 0.9×	16 0.6×	19	312
Sen-Lin Zhou United States	6	97 0.7×	22 0.5×	23 0.5×	30 0.9×	24 0.9×	7	265
Na He China	11	109 0.8×	33 0.7×	45 1.0×	100 3.1×	21 0.8×	41	350
Mi Lai China	11	107 0.7×	56 1.2×	42 0.9×	41 1.3×	37 1.3×	13	345

Countries citing papers authored by Benjamin Bourgeois

Since Specialization

Citations

This map shows the geographic impact of Benjamin Bourgeois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Bourgeois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Bourgeois more than expected).

Fields of papers citing papers by Benjamin Bourgeois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Bourgeois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Bourgeois. The network helps show where Benjamin Bourgeois may publish in the future.

Co-authorship network of co-authors of Benjamin Bourgeois

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Bourgeois. A scholar is included among the top collaborators of Benjamin Bourgeois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Bourgeois. Benjamin Bourgeois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bourgeois, Benjamin, Emil Spreitzer, Margret Paar, et al.. (2025). The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI. Nature Communications. 16(1). 5672–5672. 3 indexed citations

Anisimova, Aleksandra S., et al.. (2024). IGF2BP1 phosphorylation in the disordered linkers regulates ribonucleoprotein condensate formation and RNA metabolism. Nature Communications. 15(1). 9054–9054. 2 indexed citations

Abuja, Peter M., Benjamin Bourgeois, Martina Loibner, et al.. (2023). Residual Humidity in Paraffin-Embedded Tissue Reduces Nucleic Acid Stability. International Journal of Molecular Sciences. 24(9). 8010–8010. 1 indexed citations

Spreitzer, Emil, T. Reid Alderson, Benjamin Bourgeois, et al.. (2022). FOXO transcription factors differ in their dynamics and intra/intermolecular interactions. SHILAP Revista de lepidopterología. 4. 118–133. 14 indexed citations

Horvath, Angela, et al.. (2022). Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis. Nutrients. 14(4). 748–748. 6 indexed citations

Zhang, Fangrong, Gesa Richter, Benjamin Bourgeois, et al.. (2021). A General Small-Angle X-ray Scattering-Based Screening Protocol for Studying Physical Stability of Protein Formulations. Pharmaceutics. 14(1). 69–69. 6 indexed citations

Reisinger, Alexander C., Florian Posch, Gerald Hackl, et al.. (2021). Branched-Chain Amino Acids Can Predict Mortality in ICU Sepsis Patients. Nutrients. 13(9). 3106–3106. 23 indexed citations

Taschler, Ulrike, Oliver Domenig, Marko Poglitsch, et al.. (2020). Dipeptidyl peptidase 3 modulates the renin–angiotensin system in mice. Journal of Biological Chemistry. 295(40). 13711–13723. 40 indexed citations

Bogár, Ferenc, Saša Kazazić, Hrvoje Brkić, et al.. (2020). Binding of dipeptidyl peptidase III to the oxidative stress cell sensor Kelch-like ECH-associated protein 1 is a two-step process. Journal of Biomolecular Structure and Dynamics. 39(18). 6870–6881. 7 indexed citations

10.

Lienhart, Wolf‐Dieter, Altijana Hromić‐Jahjefendić, Benjamin Bourgeois, et al.. (2019). A small molecule chaperone rescues the stability and activity of a cancer‐associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro. FEBS Letters. 594(3). 424–438. 8 indexed citations

11.

Koyani, Chintan N., Benjamin Bourgeois, Ioanna Plastira, et al.. (2018). Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes. Frontiers in Physiology. 9. 1622–1622. 19 indexed citations

12.

Koch, Karin, et al.. (2018). Oxidative stress‐induced structural changes in the microtubule‐associated flavoenzyme Irc15p from Saccharomyces cerevisiae. Protein Science. 28(1). 176–190. 1 indexed citations

13.

Bourgeois, Benjamin & Tobias Madl. (2018). Regulation of cellular senescence via the FOXO4‐p53 axis. FEBS Letters. 592(12). 2083–2097. 91 indexed citations

14.

Lienhart, Wolf‐Dieter, Venugopal Gudipati, Karin Koch, et al.. (2017). Catalytic competence, structure and stability of the cancer‐associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1). FEBS Journal. 284(8). 1233–1245. 27 indexed citations

15.

Brégeon, C, M Boasson, M Bernat, et al.. (1979). [Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973].. PubMed. 45(7-9). 453–61. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact